[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  seat11a - Gateway to In-Depth Financial Insights [@seat11a_com](/creator/twitter/seat11a_com) on x XXX followers Created: 2025-07-18 11:10:50 UTC Carl Zeiss Meditec China Deep Dive – Resilient Growth, Local Focus Carl Zeiss Meditec has grown China into its #1 country market, contributing over a quarter of group revenues. In this detailed investor presentation, Sebastian Frericks outlines: ✔ ZEISS’ strategic response to VBP and policy shifts ✔ The surge in premium IOLs and cataract procedures ✔ Continued market leadership in refractive surgery with the VISUMAX® XXX With strong brand recognition, local manufacturing, and China-specific R&D, ZEISS is well-positioned to sustain long-term leadership. 📺 Watch the full deep dive on seat11a. #MedicalDevices #HealthcareInvesting #ChinaStrategy #ZeissVision #Ophthalmology #seat11a $AFX @ZEISSmeditec 📲 Follow seat11a: 🔗 Website: 📢 LinkedIn: 🐦 Twitter: 🎧 Spotify: T&C:  XX engagements  **Related Topics** [surge](/topic/surge) [investment](/topic/investment) [china](/topic/china) [$afxde](/topic/$afxde) [carl zeiss](/topic/carl-zeiss) [Post Link](https://x.com/seat11a_com/status/1946165761128665253)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
seat11a - Gateway to In-Depth Financial Insights @seat11a_com on x XXX followers
Created: 2025-07-18 11:10:50 UTC
Carl Zeiss Meditec China Deep Dive – Resilient Growth, Local Focus Carl Zeiss Meditec has grown China into its #1 country market, contributing over a quarter of group revenues.
In this detailed investor presentation, Sebastian Frericks outlines: ✔ ZEISS’ strategic response to VBP and policy shifts ✔ The surge in premium IOLs and cataract procedures ✔ Continued market leadership in refractive surgery with the VISUMAX® XXX
With strong brand recognition, local manufacturing, and China-specific R&D, ZEISS is well-positioned to sustain long-term leadership.
📺 Watch the full deep dive on seat11a.
#MedicalDevices #HealthcareInvesting #ChinaStrategy #ZeissVision #Ophthalmology #seat11a $AFX @ZEISSmeditec
📲 Follow seat11a: 🔗 Website: 📢 LinkedIn: 🐦 Twitter: 🎧 Spotify:
T&C:
XX engagements
Related Topics surge investment china $afxde carl zeiss
/post/tweet::1946165761128665253